Hints and tips:
Related Special Reports
...It has also worked on drug development for US pharma company Johnson & Johnson, Danish biotech group Genmab and British biotech Iksuda therapeutics....
...a medical equipment company that won more than £200mn of UK state contracts during the pandemic....
...This month’s acquisition of a 15 per cent stake in the Amsterdam-based medical devices group was Exor’s biggest deal since selling US reinsurer PartnerRe for €9bn in 2021 and marks a further push into healthcare...
...Investment in the area has ramped up in recent years, with global merger and acquisition deals for vaccine-related biotech companies peaking at almost £5bn in 2021, according to figures from Dealogic....
...With a handful of companies expected to go public over the next 18 months, selectivity is key....
...“I would view this acquisition as potentially the start of a larger [vaccine] franchise and not just a one-off,” said Barker....
...Amazon Prime members will be able to access US healthcare provider One Medical’s suite of benefits, for a fee, as the ecommerce company looks to expand its presence in the $4tn American healthcare industry...
...Companies jostling to take advantage of this shift are driving a new wave of mergers and acquisitions in the healthcare industry....
...It comes amid predictions from mergers and acquisitions bankers that the country’s shrinking and greying population will increasingly push corporate Japan into an era of rapid consolidation....
...Investors like to hear a bullish story from companies, too....
...The company expects the acquisitions to increase its capacity to make drugs, including Ozempic and Wegovy, from 2026 onwards....
...Merck and medical device maker Boston Scientific also announced acquisitions. The tail-end of last year also ushered in big deals....
...This year, the Bad Homburg-based group spun off its dialysis business Fresenius Medical Care after a string of profit warnings, partially because many of the company’s clients passed away during the Covid...
...Exor’s sudden acquisition of a 15 per cent exposure to Philips stock, worth €2.6bn, is not a complete surprise....
...Despite that, the company has taken steps to end the protracted crisis over Roundup, which Bayer acquired as part of its ill-fated $63bn acquisition of US crop sciences business Monsanto in 2016....
...Yet it is throwing itself into a takeover battle against M3, a Sony-backed medical information provider that is also bidding for Benefit One....
...“A company can add several percentage points of margin into their acquisition [through group drug purchasing]....
...It said that USAP’s commercial rates did not exceed the rate of medical cost inflation for nearly 10 years....
...The acquisition target is Benefit One, a company in hot demand in the era of labour shortage when higher wages are not enough to attract workers....
...In a separate New York case, Alberto already secured the disclosure of Joseph’s medical records, with which he intends to challenge wills his father wrote in Switzerland....
...Hulu’s future has been in limbo since 2019, when Disney lifted its stake in the company to 67 per cent through its blockbuster acquisition of 21st Century Fox....
...Jez Maiden will become chair of the audit committee for medical technology group Smith & Nephew from March....
...In September, UK private equity house Cinven struck a deal to buy back the outstanding shares in Synlab, a laboratory and medical diagnostic services company in which it retained a 40 per cent stake, after...
...Founded in 2004, Circle grew through the acquisition of the larger BMI Healthcare in 2019....
...Smith & Nephew wants to increase pay for its US executives to bring it closer to American levels, with Rupert Soames, the chair of the FTSE 100 medical devices company calling UK pay packages “not sustainable...
International Edition